Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03153449 · ClinicalTrials.gov registry record · NA

ATTUNE® Revision- Complex Primary in Total Knee Arthroplasty Population

A NA study of Primary Knee Arthroplasty, sponsored by DePuy Orthopaedics.

Active
Registry status
NA
Development phase
400
Enrollment target
20
Study locations

NCT03153449: Active NA study of Primary Knee Arthroplasty, sponsored by DePuy Orthopaedics.

NCT03153449 is a NA study of Primary Knee Arthroplasty that is active but no longer recruiting, run by DePuy Orthopaedics. The registered enrollment target is 400 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (72% lower). The trial reports 20 study locations across 14 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03153449, a NA study of Primary Knee Arthroplasty, is active but no longer recruiting, sponsored by DePuy Orthopaedics.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
400 participants
Enrollment target
20
Study locations

Study Summary

Five-year, Prospective, multi-center, non-randomized, non-controlled study of the ATTUNE® Revision total knee prostheses, utilizing the fixed bearing (FB) and rotating platform (RP) tibial component with the posterior stabilizing (PS) femoral component in complex primary total knee arthroplasty.

Primary Outcome

Evaluate change from preoperative baseline to the 2 yr timepoint in patient reported functional outcome, KOOS-ADL for the ATTUNE® Revision TKA FB and RP configurations.

Conditions Studied

Interventions

  • DEVICE ATTUNE Revision Knee System in Total Knee Arthroplasty

Study Locations (20)

Other

  • Fremantle Hospital - Fremantle
  • St. John of God Murdoch Hospital - Perth
  • Krankenhaus der Barmherzigen Schwestern Linz Betriebsgesellschaft m.b.H. - Linz
  • Concordia Joint Replacement - Winnipeg

Colorado

  • Colorado Joint Replacement - Denver
  • Orthopaedic Center of the Rockies - Fort Collins

North Carolina

  • UNC Orthopaedics - Chapel Hill
  • OrthoCarolina Hip and Knee Center - Charlotte

Texas

  • Texas Institute for Hip & Knee Surgery - Austin
  • Fondren Orthopedic Group - Houston

California

  • Scripps Clinic Torrey Pines - San Diego

Connecticut

  • Orthopedic Partners - Niantic

Florida

  • Florida Orthopedic Associates - DeLand

Kentucky

  • Arthroplasty Foundation - Louisville

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2017-09-19
Est. Completion 2028-06-30
Phase NA
DePuy Orthopaedics

38 total trials

What the registry record for NCT03153449 still lists

NCT03153449 is an interventional study that assigns participants to a tested intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (72% lower).

The record links to 1 condition, with Primary Knee Arthroplasty appearing as the primary indexed condition, and to 1 intervention - of which ATTUNE Revision Knee System in Total Knee Arthroplasty is the first listed.

NCT03153449 names 20 study sites across 14 states, led by Other, Colorado, North Carolina.

Frequently Asked Questions

What is clinical trial NCT03153449 about?

NCT03153449 is a clinical study titled "ATTUNE® Revision- Complex Primary in Total Knee Arthroplasty Population". Five-year, Prospective, multi-center, non-randomized, non-controlled study of the ATTUNE® Revision total knee prostheses, utilizing the fixed bearing (FB) and rotating platform (RP) tibial component with the posterior stabilizing (PS) femoral component in complex primary total knee arthroplasty.

What is the current status of trial NCT03153449?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 400 participants. The study started on 2017-09-19. Estimated completion is 2028-06-30.

What conditions does trial NCT03153449 study?

This clinical trial studies the following conditions: Primary Knee Arthroplasty.

What interventions are being tested in trial NCT03153449?

The interventions under investigation include: ATTUNE Revision Knee System in Total Knee Arthroplasty (DEVICE).

Who is sponsoring clinical trial NCT03153449?

This trial is sponsored by DePuy Orthopaedics, which has 38 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03153449 being conducted?

This trial has 20 study locations across California, Colorado, Connecticut, Florida, Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

How this trial's enrollment target compares

Where NCT03153449's enrollment target sits among peer trials

400 246th of 2000 higher than 1,734 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01665326 · 400 participants

    Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease

  • NCT02108054 · 400 participants · NA

    Behavioral and Functional Task Development, Implementation, and Testing

  • NCT02216500 · 400 participants · NA

    Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy

  • NCT02250352 · 400 participants

    Core Biopsies for Establishing a Breast Tumor Tissue Repository

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03153449, the US trial registry maintained by the National Library of Medicine. NCT03153449 (mid enrollment · wide site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.